Vol. 44 No. 8 (2005): Acta Oncologica

Articles

• Steepness of the radiation dose-response curve for dose-per-fraction escalation keeping the number of fractions fixed

  Søren M. Bentzen

  825-828

  Published: 2005-01-01

  • PDF

• The potential of proton beam therapy in paediatric cancer

  Thomas Björk-Eriksson, Bengt Glimelius

  871-875

  Published: 2005-01-01

  • PDF

• The potential of proton beam radiation therapy in gastrointestinal cancer

  Anders Ask, Bengt Johansson, Bengt Glimelius

  896-903

  Published: 2005-01-01

  • PDF

• Kinase domain mutation of NTRK3 gene is uncommon in gastric carcinomas

  Jong Woo Lee, Young Hwa Soung, Su Young Kim, Won Sang Park, Jung Young Lee, Nam Jin Yoo, Sug Hyung Lee

  924-925

  Published: 2005-01-01

  • PDF

• Can risk of radiotherapy-induced normal tissue complications be predicted from genetic profiles?

  Christian Nicolaj Andreassen

  801-815

  Published: 2005-01-01

  • PDF

• Proton therapy of cancer: Potential clinical advantages and cost-effectiveness

  Jonas Lundkvist, Mattias Ekman, Suzanne Rehn Ericsson, Bengt Jönsson, Bengt Glimelius

  850-861

  Published: 2005-01-01

  • PDF

• The potential of proton beam radiation therapy in breast cancer

  Thomas Björk-Eriksson, Bengt Glimelius

  884-889

  Published: 2005-01-01

  • PDF

• The potentials of proton beam radiation therapy in malignant lymphoma, thymoma and sarcoma

  Thomas Björk-Eriksson, Göran Bjelkengren, Bengt Glimelius

  913-917

  Published: 2005-01-01

  • PDF

• Swedish protons

  Michael Goitein, Gudrun Goitein

  793-797

  Published: 2005-01-01

  • PDF

• Dose-effect models for risk – relationship to cell survival parameters

  Alexandru Daşu, Iuliana Toma-Daşu

  829-835

  Published: 2005-01-01

  • PDF

• The potential of proton beam radiation therapy in head and neck cancer

  Anders Ask, Thomas Björk-Eriksson, Björn Zackrisson, Erik Blomquist, Bengt Glimelius

  876-880

  Published: 2005-01-01

  • PDF

• Adjuvant chemotherapy in colorectal cancer: A joint analysis of randomised trials by the Nordic Gastrointestinal Tumour Adjuvant Therapy Group

  Bengt Glimelius, Olav Dahl, Björn Cedermark, Anders Jakobsen, Søren M. Bentzen, Hans Starkhammar, Henrik Grönberg, Ragnar Hultborn, Maria Albertsson, Lars Påhlman, Kjell-Magne Tveit

  904-912

  Published: 2005-01-01

  • PDF

• IAEA's role in the global management of cancer-focus on upgrading radiotherapy services

  Eeva Salminen, Joanna Izewska, Pedro Andreo

  816-824

  Published: 2005-01-01

  • PDF

• The potential of proton beam radiation therapy in intracranial and ocular tumours

  Erik Blomquist, Göran Bjelkengren, Bengt Glimelius

  862-870

  Published: 2005-01-01

  • PDF

• The potential of proton beam radiation therapy in prostate cancer, other urological cancers and gynaecological cancers

  Bengt Johansson, Mona Ridderheim, Bengt Glimelius

  890-895

  Published: 2005-01-01

  • PDF

• Preoperative sequential short-term radiotherapy plus chemotherapy can induce complete remission in T3N2 rectal cancer

  Joachim Widder, Friedrich Herbst, Werner Scheithauer

  921-923

  Published: 2005-01-01

  • PDF

• Protons. A step forward or perhaps only more expensive radiation therapy?

  Olav Dahl

  798-800

  Published: 2005-01-01

  • PDF

• Number of patients potentially eligible for proton therapy

  Bengt Glimelius, Anders Ask, Göran Bjelkengren, Thomas Björk-Eriksson, Erik Blomquist, Bengt Johansson, Mikael Karlsson, Björn Zackrisson

  836-849

  Published: 2005-01-01

  • PDF

• The potential of proton beam radiation therapy in lung cancer (including mesothelioma)

  Göran Bjelkengren, Bengt Glimelius

  881-883

  Published: 2005-01-01

  • PDF

• The potential of proton beam radiation for palliation and reirradiation

  Thomas Björk-Eriksson, Anders Ask, Bengt Glimelius

  918-920

  Published: 2005-01-01

  • PDF